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EDITORIAL REVIEW
The concept of bicarbonate distribution space: The crucial role
of body buffers
Severe acidemia, specially that resulting from metabolic
acidosis, is often clinically managed by administering a "bolus"
of sodium bicarbonate. Applying the pharmacological concept
of volume of distribution, a distribution volume for bicarbonate,
or apparent bicarbonate space (A.B.S.), is defined as the ratio
of administered bicarbonate to the observed change in the
plasma bicarbonate concentration. Under normal conditions
the A.B.S. is 40% to 50% of total body weight or approximately
twice the extracellular fluid volume. Although some early
studies had suggested that the A.B.S. is constant in a given
animal [1], clinical observations have led to the recognition that
the A.B.S. expands in severe metabolic acidosis [21. Confirming
these clinical observations in experimental animals, Garella,
Dana and Chazan [21 and Russell et a! [31 also demonstrated
that metabolic alkalosis reduces the A.B.S.
In detailed studies some thirty years ago, Swan et al [4] and
Singer et alES] analyzed the contributions of intra- and extra-
cellular buffering and transcellular bicarbonate fluxes to the
A.B.S. Since non-bicarbonate buffers, in their protonated
forms, titrate a fraction of the administered bicarbonate to
carbon dioxide and water, these buffers were considered to
contribute to the size of the apparent bicarbonate space. It was
then natural to assume that under conditions of acidemia those
buffers, being in a highly protonated form, would represent an
expanded pooi of H which was available to titrate a propor-
tionately greater fraction of the administered bicarbonate. In
alkalemia the non-bicarbonate buffers would have fewer pro-
tons available to titrate the added bicarbonate. According to
this line of reasoning, the starting pH was the main determinant
of the A.B.S., since it reflected the degree of protonation of
non-bicarbonate buffers.
It was in 1983 that the interesting experimental observations
of Adrogud et a! [61 raised major questions about the validity of
the above concepts. They showed that the A.B.S. decreased in
dogs with acidemia due to chronic respiratory acidosis, while it
increased in dogs with alkalemia due to chronic respiratory
alkalosis. Those investigators also confirmed the already known
expansion and contraction of the A.B.S. in metabolic acidosis
and in metabolic alkalosis, respectively. Altogether, their find-
ings indicated that the A.B.S. is largely independent of blood
pH, while it exhibits marked dependence on the initial plasma
bicarbonate concentration.
Intuitively, it is difficult to understand why pH, which ex-
presses the degree of protonation of non-bicarbonate buffers, is
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not a major determinant of the A.B.S., and why the A.B.S.
varies mainly as a function of the plasma bicarbonate concen-
tration. By employing chemical principles of buffering, we
found that the behavior of the A.B.S. is fully predictable on the
basis of the body's buffer systems, which include non-volatile
buffers and a volatile buffer system open to the atmosphere, the
HCO/CO2 system. We describe a simple model of the A.B.S.
which integrates the chemical and physiological behavior of
these biological buffers and numerically reproduces the exper-
imental results of Adrogué et al [61. The principles of biological
buffering are discussed first. This is followed by a description of
a model of the A.B.S., and its mathematical derivation. Data
previously published by several investigators will then be
analyzed within the previously considered concepts of buff-
ering. The results obtained are then utilized to develop a simple
equation with potential application to the analysis of human
acid-base disturbances.
Biological buffering
Non-bicarbonate buffering. Figure lA shows the classical
sigmoid titration curve of a buffer system consisting of a weak
acid and its alkaline salt. The ordinate represents the dissoci-
ated anion concentration, [A], remaining in a 0.1 M solution as
pH is altered by H or OH— addition. The sigmoidal shape of
the curve indicates that at low pH's essentially all the buffer is
undissociated, AH, while at high pH's the buffer is dissociated,
A. The buffering power of the system (usually identified as 13),
that is, its capacity to protect the pH when a given amount of
H or OH is added, is determined by the slope of the sigmoid
curve, d[A]/dpH, Figure lB. Where the slope reaches its
maximal value, the buffering power is maximal and the buffer is
at its P1a Moving away from the PKa of the buffer, in either
direction, the buffering power decreases as is indicated by the
decline in d[Ai/dpH, until it reaches a minimum at both
extremes of the pH range.
Bicarbonate buffering. The bicarbonate buffering system may
be either closed or open. A closed system refers to a system
that has a constant amount of total C02, that is, the sum of CO2
and HCO remains unchanged despite the addition of W or
0H. Such a closed system behaves exactly as the one de-
scribed in Figure 1. An open system refers to a system that has
a fixed amount of dissolved C02, but a variable HCO concen-
tration that changes as H or 0H is added. Consequently, in
an open system total CO2 content changes. This system is the
biologically important one, as PCO2 is determined by ventila-
tion while the HCO concentration can undergo dramatic
changes.
Since biological systems approximate open systems and
H2C03 concentration remains fairly constant, the titration
curve (Fig. 2) differs markedly from the sigmoid curve of the
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Fig. 1. Buffering in a closed system containing HA and A. In a closed system the total concentration of HA and A is constant. In this example
the total concentration of HA and A is 0.1 M and the PKa is 7. A. Addition of 0H titrates all the anion to A, while addition H titrates A to
HA. At pH 7, that is, the PKa, 50% of this buffer system is in the A form and 50% is in the form of HA. B. The derivative of A/HA buffer system,
that is, the slope of the curve in panel A, is a measure of its buffering power, /3, and attains its maximum value at the pK.
closed system (Fig. 1). Inspection of Figure 2 reveals that the
buffering power of such a system (/3), as determined by the
value of the slope, d[A]/dpH, is now a continuously increasing
value. This relates to the fact that addition of 0H to the
system generates a practically limitless amount of A (HCO),
as the added OH— reacts with CO2 to form HCO, while the
level of CO2 remains constant. In other words, the buffering
power of this system increases as the HCO concentration
increases. Figure 2 also shows that the buffering power of this
system is the same at any given bicarbonate concentration and
is independent of pH, as pH can be varied over a wide range by
modifying PCO2.
Buffering power of non-bicarbonate buffer and bicarbonate
systems. The buffering power of non-bicarbonate buffers de-
pends upon their PKa, the starting pH, and the total concentra-
tion of buffer. Mathematically, the buffering power (f3floflHCO)
is given by the first derivative of the equation defining the
titration curve, as such a derivative expresses the slope of the
latter curve [7]. Thus:
d[A] (Ka x H)
f3nonHco; = = 2.303 x C x (Ka + H)2
where C is the molar concentration of the buffer and Ka is its
dissociation constant.
The buffering power of an open bicarbonate buffer system
(/3Hco;) is, on the other hand, given by the following equation
[7]:
d[HCO]
/3HCO- = = 2.303 x [HCO31
dpH
which reveals the exclusive dependence of the buffering power
of the system on the HCO concentration.
When both buffer systems coexist, added H or OH— are
titrated by both types of buffers. The amount of H or 0H
titrated by either system is proportional to the absolute buff-
ering power of each system at the time when H and 0H are
added. Functionally, when /3nonHCO considerably exceeds
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Fig. 2. Buffering in an open system containing CO2 and HCO. In this
open system CO2 tension is constant while HCO concentration varies;
the apparent PKa is 6.1. A. Addition of OH at different CO2 tensions
increases the HCO concentration (left ordinate) and the buffering
power, /3, (right ordinate). B. The derivative of the HCOjICO2 buffer
system, that is, the slope of the upper panel, is a measure of its buffering
power, p, and is independent of pH (Eq. 2). /3HCO increases linearly
with the HCO concentration at any PCO2 and, consequently, at
varying pH's.
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I3Hco, added H or OH- is titrated mainly by the nonHCO
buffer and the HCO concentration changes minimally. On the
contrary, when /3HCO is significantly greater than i3nonHco;' the
HCO buffer system is the predominant system, and added H
or 0H changes the HCO concentration.
Space of Distribution of Bicarbonate
Apparent bicarbonate space (A.B.S.)
Operationally, the A.B.S. is defined as the ratio of the
amount of HCO administered to the observed change in the
plasma HCO concentration, [HCOfl, or:
Administered HCO
It is assumed that there is neither external HCO loss, nor an
overwhelmingly high rate of acid production, and that the
administered HCO distributes or mixes at a rather fast rate.
Physiologically, the A.B.S. has two components, an actual or
real body fluid volume through which a fraction of administered
HCO is diluted (dilutional space, D.S.) and a HCO sink in
which the remaining fraction of administered HCO is titrated
by non-bicarbonate buffers. This titration takes place in a body
space that will be called the titration space (T.S.). We can thus
write:
Administered HCO =
HCO over D.S. + HCO titrated in T.S., (4)
D.S. and T.S. are purely functional terms, and not actual
physical spaces corresponding to any body fluid compartments.
Assuming that the D.S. and the T.S. remain constant, and that
the concentration of HCO distributed through the D.S. is
uniform and equal to the observed change in plasma HCO
concentration, we have:
and
HCO over D.S. = D.S. x
HCO titrated in T.S. = T.S. x [A],
where [A} is the concentration of nonHCO buffer. We can
now calculate the A.B.S. from equations 3 to 6, above:
A.B.S. = D.S. + T.S. x[HCO3i
Dividing the above equation by pH/pH:
buffering power of non-bicarbonate buffering systems to the
buffering power of the open bicarbonate system. Moreover,
since D.S. and T.S. are assumed to be constant, the ratio of
buffering powers determines the A.B.S. Although the denomi-
nator of the ratio, that is, the buffering power of bicarbonate
(I3Hco)' is independent of pH (Eq. 2), the numerator, that is,
the buffering power of non-bicarbonate buffers (/3floflHco) is
affected by pH (Eq. 1). This suggests that pH may influence the
A.B.S. However, as discussed next, I3nonHCO appears to vary
little over the physiologic range of pH abnormality, and,
accordingly, pH has little effect on the A.B.S.
Non-bicarbonate body buffers
(3) Utilizing Equation 8 to calculate the A.B.S. requires knowl-edge of the buffering values, /3, for both HCO and nonHCO
buffer systems. While /3Hco can be readily calculated for any
plasma bicarbonate concentration, a value applicable
to the whole body is not so clearly identified, since
includes extra- and intra-cellular phosphates and proteins with
a wide variety of PKa values. It is possible, however, to
estimate values for whole body /3nOnHCOi in humans by re-
examining the in vivo CO2 titration experiments that serve as
the template for the acute respiratory acidosis and alkalosis
confidence intervals found on acid-base nomograms. Alter-
ations in the body content of CO2 gas are buffered both, extra-
and intra-cellularly. Consequently, the magnitude of the pH
change induced by a given displacement of the body's CO2 gas
content is a reflection of the combined extra- and intra-cellular
buffering power.
During whole body CO2 titration, plasma HCO concentra-
tion changes, reflecting the buffering effects of extra- and
intra-cellular nonHCO buffers. Although the change in HCO
concentration divided by the change in pH should yield an
estimate for the whole body buffering, Madias and Adrogu [8,
9] recently suggested that other factors, such as the rate of
HCO transfer across cell membranes, also influence the
change in plasma HCO concentration during CO2 titration.
Thus, we considered an alternative approach, one based on
plotting the CO2 titration data on a log PCO2 versus pH
coordinate system. For decades the log PCO2-pH coordinate
system has been used, because in vitro and in vivo biologic
titration results yield a straight line [3, 7—10, 13]. In simple
solutions buffered by CO2 and HCO only, for example,
rearrangement of the Henderson-Hasselbalch equation demon-
strates that the slope of this plot, d(log PCO2)/dpH, is —I.
Furthermore, the slope is independent of the HCO concentra-
tion and pH, with the proviso that the pH is not too alkaline to
be affected by the equilibrium between HCO and COY. The
addition of nonHCO buffers increases the slope, adds some
dependence on pH, and can be represented by the following
approximation [7, 10]:
(8)
In this form, the numerator and denominator in the second
term of the equation become the buffer values of the nonHCO
and of the HCO buffer systems, respectively. It then becomes
apparent that the A.B.S. is influenced by the ratio of the
The slope of the CO2 titration curve is readily available and
provides a potentially convenient mechanism for obtaining
A.B.S. =
(5)
(6)
A.B.S. = D.S. + T.S. x
pH d(IogPCO2)dpH
/3nonHCO
1— =—l—
I3i.ico;
(9)
d[HCO]
dpH
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Fig. 3. Human acute CO5 titration data reported by Brackett et a/Ill]
and Arbus et a! [12]. These data fit the line, tog PCO2 = —1.33 X pH +
11.47 (N = 33, r = 0.99, P < 0.001).
estimates of I3nonHCO for in vitro and in vivo conditions. For
example, the widely used whole body human CO2 titration data
of Brackett, Cohen and Schwartz [11] and Arbus et al [121 fit a
single straight line (log PCO2 = —1.33 X pH + 11.47, r = 0.99,
P < 0.001, Fig. 3), yielding a d(log PCO2)/dpH value of —1.33
for normal humans. Entering this value and the PHCO value of
55 mEq/liter/pH (obtained from Eq. 2 and [HCOfl 24
mEq/liter) into Eq. 9, it is estimated that the /3nonHCO value at
normal acid-base conditions is 18 mEq/liter/pH. Furthermore,
CO2 titration data in humans and animals under conditions of
acute and chronic acid-base disturbances of metabolic and
respiratory origin also fit straight lines [3, 7—9, 131, although the
slopes vary from that of normal humans.
Since, in a given individual, CO2 titration yields a straight
line, that is, d(log PCO2)/dpH is constant, while the HCO
concentration varies, it follows from Eq. 9 that /3nonHCO also
varies over the titration range. Utilizing the data of Brackett et
al[11] and Arbus et al [12] as well as data from Stoker et al [131,
obtained in humans with acute metabolic acidosis and alkalosis,
the values of I3nonHCO were calculated for blood pH's ranging
from 7.0 to 7.7 and are graphically depicted in Figure 4. While
the value of l3nonHCO increases in metabolic (line "B") and
respiratory (line "A") situations at the lower blood pH's, the
increase is more marked in metabolic than in respiratory
acidosis; at pH 7.6, the value of I3nOnHCO is almost identical in
both metabolic and respiratory alkalosis. Combining the data,
the average value of f3noflHCO for blood pH's of 7.0 to 7.2 is
about 24 mEq/liter/pH, while its value at pH's of 7,5 to 7.7
approximates 15 mEq/liter/pH. These "whole body" buffer
values are higher than those described for plasma [7], but lower
than those reported for erythrocyte contents [71.
Interaction between buffer systems
Having a functional method to estimate values of /3nonHCO
for the whole body, we can evaluate how the two buffer systems
interact and affect the A.B.S. As noted above, /3nonHcO
changes relatively little over the clinically relevant range of
acid-base disturbances. In contrast, the value of I3HCO differs
markedly. Importantly, in vitro studies confirm the relative
constancy of the I3nonHCO value over the pH range of clinical
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Fig. 4. Values of !3,,,,,RcO for humans. Line "A" was obtained using
the data of Brackett et al [11] and Arbus et al [12] (Fig. 3) and represents
the effects of pH changes induced by acute respiratory disturbances of
acid-base balance on PnOnHCO. Line "B" was obtained from the data of
Stoker et at [13] and represents the effects of pH changes induced by
acute metabolic disturbances of acid-base balance on /3nonHCO at PCO2
=40 mm Hg.
acid-base disturbances [7]. Thus, in metabolic acid-base distur-
bances when the HCO concentration changes from 5 mEq/
liter to 40 mEq/liter and pH changes from 7.1 to 7.6, I3HCO
increases 800% from 11.5 mEq/liter/pH to 92 mEq/liter/pH,
while /3nonHCOT decreases only 33%, 24 mEq/liter/pH to 15
mEq/liter/pH. In so far as the A.B.S. is influenced by the ratio
f3nonwc3 tO /3HCO (Eq. 8) and PnonHCO is near constant, the
A.B.S. varies predominantly with the reciprocal of I3Hc03.
Moreover, since 13HC03 is a linear function of the HCO
concentration (Eq. 2), the A.B.S. is logically expected to
exhibit a major reciprocal dependence on the HCO concen-
tration. This predicted behavior of the A.B.S. has been exper-
imentally confirmed by the animal data of Adrogud et a! [6].
It becomes evident also that the total buffer value for the
whole body, that is, the sum of I3HCO and f3floflHCo' increases
mainly as a function of the plasma HCO concentration. Its
value is relatively small at low plasma HCO concentrations,
that is, metabolic acidosis and respiratory alkalosis, and in-
creases at high HCO concentrations, that is, metabolic alka-
losis and respiratory acidosis. When the total buffering value is
low, addition of a given amount of H or OH— will result in a
much larger change of pH than when the total buffering value is
high. Compared to the addition of HCO at high buffering
values, the addition of HCO at low buffering values will result
in a smaller change in HCO concentration, as proportionately
more of the added HCO is dissipated by titration to CO2.
Thus, after infusion of HCO, the amount of HCO consumed
by titration, as well as the simultaneous pH change, will vary
inversely with the plasma HCO concentration.
A model for human acid-base disturbances
As shown above the concept of the A.B.S. rests on the
integrated behavior of HCO and nonHCO buffers, and is
simply restated as:
13 nonHCO;A.B.S. = D.S. + T.S. x . (10)
PHCO
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Applying available human data, a numerical form of this equa-
tion can be developed. In normal humans, the A.B.S. averages
50% of body weight (body wt) and expands to 100% of body
weight in severe metabolic acidosis when [HCOfl is 5 mEq/
liter [2]. With these A.B.S. values and the estimated 1 values
for the two buffers systems (Fig. 4, eq. 2), estimates for the
dilutional space and the titration space can be obtained using
equation 10 and solving two equations with two unknowns.
Thus, in functional terms, HCO appears to distribute over
40% of body weight, or D.S. = 0.4 x body wt, and appears to
be titrated in a space equivalent to 30% of body weight, or T.S.
= 0.3 x body wt. Whereas we cannot assign specific anatomic
regions to these spaces, it is of interest that the extracellular
fluid volume is half the value for the dilutional space, raising the
possibility that half of the HCO is distributed in intracellular
fluid or titrated by H exit from this pool.
Incorporating these values into equation 10 yields:
I3nonHCO 1
A.B.S. = 0.4 + 0.3 x x body wt. (11)
I3HCO; ]
This form of the equation permits us to examine the quantitative
influences of variations in /3nonHCO and I3HcO as pH and
HCO change over a clinically relevant range. For example, at
HCO concentration of 5 mEq/liter the A.B.S. is 100% of body
weight, the pH is 7.1 and PnOnHCO is at its maximal value, 24
mEq/liter/pH. Should it be possible to reduce the HCO
concentration to the same extent, but maintain the pH at 7.6,
the value of f3nonHCO would be at its minimum, 15 mEq/
liter/pH, and the A.B.S. would be 80% of body weight. If,
instead of changing as a function of pH, /3nonHCO had been
assumed to be constant at 20 mEq/liter/pH, the A.B.S. would
be 90% of body weight. At the other extreme, that is, a HCO
concentration of 40 mEq/liter, a change in pH from 7.1 to 7.6
would alter the A.B.S. from 48% to 45% of body weight. Thus,
given the rather small variations that changes in /3nonHCO (due
to alterations in pH) impose upon the A.B.S., equation 9 can be
further simplified by using a constant value for PnonHCO' 20
mEq/liter/pH:
2.6
A.B.S. = 0.4 + x body wt.[HCOi
Equation 12, graphically depicted in Figure 5, shows that the
A.B.S. asymptotically approaches 40% of body weight, that is,
the dilution space, as the plasma HCO concentration in-
creases. Alterations in extracellular fluid volume, for example,
are thus expected to influence the A.B.S., and if very large must
be taken into consideration in the calculation of the latter.
Equation 12 is identical in format and remarkably similar in
numerical value to the empiric equation obtained by Adrogue et
al from experiments in dogs [6]:
2.44
A.B.S. = 0.36 + x body wt.
[HCOfl
While protonation of nonHCO extracellular and intracellu-
lar buffers was accepted earlier as an explanation of the A.B.S.
expansion in metabolic acidosis, the most recent experimental
data [6] demanded a re-evaluation of that concept. A full
understanding of the behavior of body buffers, taking into
consideration the coexistence of two buffer systems with dif-
ferent buffering properties, provides a rational explanation for
those experimental observations. The present analysis empha-
sizes the co-operational aspects of a closed nonHCO buffer
system and an open HCO buffer system. On this basis, it
underscores the importance of the plasma HCO concentra-
tion, as opposed to that of the blood pH, as the main determi-
nant of the apparent volume of distribution of administered
bicarbonate.
PEDRO C. FERNANDEZ, RAPHAEL M. COHEN and
GEORGE M. FELDMAN
Philadelphia, Pennsylvania, USA
Acknowledgments
This work was supported by the Veterans Administration. During a
portion of this analysis, Dr. Raphael Cohen was a recipient of a
Research Service Award from the Public Health Service. The authors
thank Dr. Steven Fischkoff for his help in creating the illustrations.
Reprint requests to George M. Feldman, M.D., Room A329R,
(12) Veterans Administration Medical Center, Woodland and University
Avenues, Philadelphia, Pennsylvania 19104, USA.
Appendix
To examine the behavior of "whole body" l3nonHCO as a function of
pH in metabolic and respiratory abnormalities, several algorithms can
be developed utilizing Equation 9 and the values for the slope of the log
PCO2 versus pH plot obtained from the data of Stoker et al [13] or
Siggaard-Andersen [7]. To utilize the data of Stoker et al [13], an
iterative algorithm is required to identify the single line with the
appropriate slope that runs through the data point in question and the
appropriate non-respiratory pH, that is, pH at PCOZ = 40 mm Hg. To
utilize the Siggaard-Andersen "whole body" nomogram the original
tabular data can be used iteratively [7, 14] while recognizing that blood
with a hemoglobin concentration of 5 g/dl approximates the behavior of
the whole body [7]. Also depending on a hemoglobin concentration of 5
g/dl, Englesson, Grevsten and Olin [15] observed that, within a limited
range of acid-base abnormalities, all lines tend to run through a
mathematical center, pH = 5.596 and log PCO2 = 3.958. Thus, the
slope, d(log PCO2)/dpH, for a given acid-base condition can be deter-
mined as (3.958 — log PCO2)/(5.596 — pH). The latter method yields
slightly lower values for PnonHCO than does the first method and is
limited in its range of applicability.
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Fig. 5. Variation of the apparent bicarbonate space. The curves were
calculated utilizing three values for PnonHco. the upper dashed line, 24
mEq/literlpH; solid line, 20 mEq/liter/pH; and lower dashed line, 15
mEq/liter/pH.
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